Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Jean‐Nicolas Vauthey et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancersKwang‐Yu Chang, Li-Tzong Chen, Nai‐Jung Chiang et al.|OncoImmunology|2021Cited by 44